Wells Fargo’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $247K | Buy |
32,739
+7,052
| +27% | +$53.1K | ﹤0.01% | 4264 |
|
|
2025
Q1 | $194K | Buy |
25,687
+823
| +3% | +$6.23K | ﹤0.01% | 4284 |
|
|
2024
Q4 | $303K | Buy |
24,864
+8,056
| +48% | +$98.1K | ﹤0.01% | 4042 |
|
|
2024
Q3 | $281K | Buy |
16,808
+2,916
| +21% | +$48.8K | ﹤0.01% | 3972 |
|
|
2024
Q2 | $242K | Buy |
13,892
+4,692
| +51% | +$81.8K | ﹤0.01% | 4038 |
|
|
2024
Q1 | $157K | Buy |
9,200
+1,173
| +15% | +$20K | ﹤0.01% | 4257 |
|
|
2023
Q4 | $81.8K | Buy |
8,027
+2,068
| +35% | +$21.1K | ﹤0.01% | 4617 |
|
|
2023
Q3 | $53.9K | Sell |
5,959
-3,119
| -34% | -$28.2K | ﹤0.01% | 4794 |
|
|
2023
Q2 | $97.7K | Buy |
9,078
+4,430
| +95% | +$47.7K | ﹤0.01% | 4790 |
|
|
2023
Q1 | $47.5K | Buy |
+4,648
| New | +$47.5K | ﹤0.01% | 4893 |
|
|
2022
Q4 | – | Sell |
-71
| Closed | -$1K | – | 7149 |
|
|
2022
Q3 | $1K | Sell |
71
-274
| -79% | -$3.86K | ﹤0.01% | 5965 |
|
|
2022
Q2 | $4K | Sell |
345
-10,742
| -97% | -$125K | ﹤0.01% | 5774 |
|
|
2022
Q1 | $116K | Sell |
11,087
-8,422
| -43% | -$88.1K | ﹤0.01% | 4928 |
|
|
2021
Q4 | $301K | Buy |
19,509
+19,453
| +34,738% | +$300K | ﹤0.01% | 4687 |
|
|
2021
Q3 | $1K | Sell |
56
-7,867
| -99% | -$140K | ﹤0.01% | 6334 |
|
|
2021
Q2 | $204K | Buy |
7,923
+3,828
| +93% | +$98.6K | ﹤0.01% | 4728 |
|
|
2021
Q1 | $171K | Buy |
+4,095
| New | +$171K | ﹤0.01% | 4908 |
|